Qutenza is FDA-approved for the treatment of painful diabetic peripheral neuropathy of the feet and is a medicated topical system that is applied to the feet for 30 minutes. Visit with your Study Doctor at Curalta Clinical Trials to see if you are eligible to participate in the study. This involves seeing the Study Doctor once every 12 weeks (3 months) for 9 months to receive a Qutenza application and complete a questionnaire. The questionnaire will be administered electronically using an on-site device. Additionally, you will be asked to complete an electronic questionnaire that will be sent to you one time per week for 12 weeks (3 months) after each of your three Qutenza applications.